BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2374215)

  • 1. The effect of back closure on detrusor function in neonates with myelomeningocele.
    Kroovand RL; Bell W; Hart LJ; Benfield KY
    J Urol; 1990 Aug; 144(2 Pt 2):423-5; discussion 443-4. PubMed ID: 2374215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of urodynamic evaluation in newborns with myelodysplasia.
    Bauer SB; Hallett M; Khoshbin S; Lebowitz RL; Winston KR; Gibson S; Colodny AH; Retik AB
    JAMA; 1984 Aug; 252(5):650-2. PubMed ID: 6737668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of urodynamic testing in the management of neonates with myelodysplasia: a prospective study.
    Sidi AA; Dykstra DD; Gonzalez R
    J Urol; 1986 Jan; 135(1):90-3. PubMed ID: 3941475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder and sphincter behavior in patients with spinal cord lesions.
    Kaplan SA; Chancellor MB; Blaivas JG
    J Urol; 1991 Jul; 146(1):113-7. PubMed ID: 2056568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urological evaluation of patients that had undergone in utero myelomeningocele closure: A prospective assessment at first presentation and early follow-up. Do their bladder benefit from it?
    Macedo A; Leal M; Rondon A; Ortiz V; Moron AF; Cavalheiro S
    Neurourol Urodyn; 2015 Jun; 34(5):461-4. PubMed ID: 24729268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero closure of myelomeningocele does not improve lower urinary tract function.
    Lee NG; Gomez P; Uberoi V; Kokorowski PJ; Khoshbin S; Bauer SB; Estrada CR
    J Urol; 2012 Oct; 188(4 Suppl):1567-71. PubMed ID: 22917751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic detrusor sphincter dyssynergia in neurologically normal patients with voiding abnormalities.
    Jørgensen TM; Djurhuus JC; Schrøder HD
    Eur Urol; 1982; 8(2):107-10. PubMed ID: 7060614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder-sphincter dysfunction in myelomeningocele.
    van Gool JD; Dik P; de Jong TP
    Eur J Pediatr; 2001 Jul; 160(7):414-20. PubMed ID: 11475578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
    JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The urodynamic profile of myelodysplasia in childhood with spinal closure during gestation.
    Holzbeierlein J; Pope JC IV; Adams MC; Bruner J; Tulipan N; Brock JW
    J Urol; 2000 Oct; 164(4):1336-9. PubMed ID: 10992409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voiding dysfunction: patients with human T-lymphotropic-virus-type-1-associated myelopathy.
    Yamashita H; Kumazawa J
    Urol Int; 1991; 47 Suppl 1():69-71. PubMed ID: 1949382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video urodynamic findings in men with the central cord syndrome.
    Smith CP; Kraus SR; Nickell KG; Boone TB
    J Urol; 2000 Dec; 164(6):2014-7. PubMed ID: 11061905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup.
    Hopps CV; Kropp KA
    J Urol; 2003 Jan; 169(1):305-8. PubMed ID: 12478177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retained sacral function in children with high level myelodysplasia.
    Pontari MA; Keating M; Kelly M; Dyro F; Bauer SB
    J Urol; 1995 Aug; 154(2 Pt 2):775-7. PubMed ID: 7609177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromyography of the external anal sphincter muscle during urodynamic testing in children with meningomyelocele.
    Lissens M; Van de Walle JP; Vereecken R; Bruyninckx F; Rosselle N
    Acta Belg Med Phys; 1990; 13(4):167-73. PubMed ID: 2097857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosomal myelopathy: urologic manifestations and urodynamic findings.
    Gomes CM; Trigo-Rocha F; Arap MA; Gabriel AJ; Alaor de Figueiredo J; Arap S
    Urology; 2002 Feb; 59(2):195-200. PubMed ID: 11834384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study.
    McGuire EJ; Woodside JR; Borden TA
    J Urol; 1983 Apr; 129(4):823-6. PubMed ID: 6842712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of urodynamic testing in myelodysplastic patients.
    McGuire EJ; Woodside JR; Borden TA; Weiss RM
    J Urol; 1981 Aug; 126(2):205-9. PubMed ID: 7196460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term urological impact of fetal myelomeningocele closure.
    Clayton DB; Tanaka ST; Trusler L; Thomas JC; Pope JC; Adams MC; Brock JW
    J Urol; 2011 Oct; 186(4 Suppl):1581-5. PubMed ID: 21862080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.